University of Colorado Division of Renal Diseases and Hypertension
N

Non-steroidal Aldosterone-Blocking Agents and Their Effectiveness for CKD Prevention: What Have Studies Shown About the Use of Esaxerone or Aparenone? What Are the Future Research Targets?

By University of Colorado Division of Renal Diseases and Hypertension FEATURING Natalie Beck
By University of Colorado Division of Renal Diseases and Hypertension FEATURING Natalie Beck
145 views
May 6, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

08:12
Otsuka

Treating Patients with ADPKD Who Are Experiencing Rapidly Declining …

Feat. M. Park

Featured Video

10:08
Otsuka

Treating Patients with ADPKD When Kidney Function Appears Stable

Feat. G. Tepedino

Related Videos

06:38

What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

81.4K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

20.9K views
07:17

Interview with IgA Nephropathy Patient Alistair

Leicester IgA Nephropathy

L. Iga Nephropathy

26 views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.7K views
17:26

New

IgA Nephropathy Highlights from ASN Kidney Week 2024

ASN Kidney Week 2024 Highlights

P. Canetta

250 views
21:19

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

5.4K views
11:31

New

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

97 views
15:45

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

111 views
44:41

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

111 views
18:59

Pregnancy and Kidney Transplantation

UChicago Medicine

Y. El Kassis

38 views
09:00

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

5.1K views
30:48

Clinical Trials and Advances in Kidney Transplantation

UChicago Medicine

A. Desai

40 views
30:01

Estimated Glomerular Filtration Rate Modification: Improving Access …

Michigan Medicine

S. Norman

122 views
20:13

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

217 views
16:40

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

1.9K views

APOL1 Controversies Conference Plenary: APOL1 Pathophysiology

KDIGO

D. Friedman

174 views
14:15

Some Highlights of the 2024 KDIGO CKD Guidelines

Insights From The World Congress of Nephrology 2024

K. Zuber

414 views
38:09

Multimodal Integrative Approach to Kidney Disease: Dietary Managemen…

Houston Methodist

K. Kalantar-Zadeh

414 views
58:00

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

3.3K views
26:57

Personalizing Our Approach: A Focus on Managing the Non-diabetic Pat…

KDIGO

R. Hall, W. Herrington

133 views
AUTOPLAY